Neural transplantation in animal models of multiple system atrophy: A review

Journal of Neural Transmission, Supplement

Volumn , Issue 55, 1999, Pages 103-113

  Wenning, G K ^a   Granata, R ^a   Puschban, Z ^a   Scherfler, C ^a   Poewe, W ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 3 NITROPROPIONIC ACID; APOMORPHINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LEVODOPA; NEUROTOXIN; NEUROTROPHIC FACTOR; OXIDOPAMINE; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; BEHAVIOR DISORDER; BRAIN DEGENERATION; BRAIN TRANSPLANTATION; CORPUS STRIATUM; GENE THERAPY; HUMAN; HUNTINGTON CHOREA; MEDIAL FOREBRAIN BUNDLE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVIEW; RODENT; SHY DRAGER SYNDROME; SUBSTANTIA NIGRA; ANIMAL; DISEASE MODEL; FORECASTING; MALE; PATHOLOGY; WISTAR RAT;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; DISEASE MODELS, ANIMAL; FORECASTING; HUMANS; MALE; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; RATS; RATS, WISTAR;

EID: 0032589198     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6369-6_10     Document Type: Review

References (54)

1. Anderson KD, Panayotatos N, Coran TL, Lindsay RM, Wiegand SJ (1996) Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease. Proc Natl Acad Sci USA 93: 7346-7351
2. Beal MF, Kowall NW, Ellison DW, Mazurck MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321: 168-171
3. Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB (1989) Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxic lesions. Synapse 3: 38-47
4. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by mitochondrial toxin 3-nitropropionic acid. J Neurosci 13: 4181-4192
5. Bloem BR, Irwin I, Buruma OJ, Haan J, Roos RA, Tetrud JW, Langston JW (1990) The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J Neurol Sci 97: 273-293
6. Brouillet E, Hantraye P (1995) Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates. Curr Opin Neurol 8: 469-473
7. Brundin P, Isacson O, Gage FH, Björklund A (1986) Intrastriatal grafting of dopamine-containing neuronal cell suspensions: effects of mixing with target or non-target cells. Brain Res 389: 77-84
8. Choi-Lundberg DL, Lin Q, Chang YN, Chiang YL, Hay CM, Mohajeri H, Davidson BL, Boh MC (1997) Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science 275: 838-841
9. Costantini LC, Snyder-Keller A (1997) Co-transplantation of fetal lateral ganglionic eminence and ventral mesencephalon can augment function and development of intrastriatal transplants. Exp Neurol 145: 214-227
10. Costantini LC, Vozza BM, Snyder-Keller AM (1994) Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: an anatomical and behavioral analysis. Exp Neurol 127: 219-231
11. Daniel SE (1992) Multiple system atrophy. In: Bannister R, Mathias C (eds) Autonomic failure - a textbook of clinical disorders of autonomie nervous system. Oxford Medical Publications, Oxford, pp 564-585
12. Deutch AY, Rosin DL, Goldstein M, Roth RH (1989) 3-Acetylpyridine-induced degeneration ot the nigrostriatal dopamine system: an animal model of olivoponto-cerebellar atrophy-associated parkinsonism. Exp Neurol 105: 1-9
13. Emerich DW, Winn SR, Hantraye PM, Peschanski M, Chen EY, Chu Y, McDermott P, Baetge EE, Kordower JH (1997) Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 386: 395-399
14. Fearnley JM, Lees AJ (1990) Striatonigral degeneration. A clinicopathological study. Brain 113: 1823-1842
15. Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO, Isacson O (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridium toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci USA 91:5104-5108
16. Galpern WR, Frim DM, Tatter SB, Altar CA, Beal MF, Isacson O (1996) Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplant 5: 225-232
17. Gash DM, Zhang Z, Ovadi A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380: 252-255
18. Goto S, Hirano A, Matsumoto S (1989a) Subdivisional involvment of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann Neurol 26: 766-770
19. Goto S, Hirano A, Rojas-Corona RR (1989b) Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and ist alteration in neostriatal neurodegenerative disorders. Acta Neuropathol (Berl) 78: 543-550
20. Hantraye P, Riche D, Maziere M, Isacson O (1990) A primate model of Huntington's disease: behavioural and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon. Exp Neurol 108: 91-104
21. Huang Q, Zhou D, Sapp E, Aizawa H, Ge P, Bird ED, Vonsattel JP, DiFiglia M (1995) Quinolinic acid-induced increases in calbindin D28k immunoreactivity in rat striatal neurons in vivo and in vitro mimic the pattern seen in Huntington's disease. Neuroscience 65: 397-407
22. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism inducing neurotoxin, N-melhyl-4-phenyl-1,2,3,6-letrahydropyridinc: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82: 2173-2177
23. Kato S, Nakamura H (1990) Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: Immunohistochemical and ultrastructural studies. Acta Neuropathol (Berl) 79: 584-594
24. Lanlos PL (1997) Multiple system atrophy, Brain Pathol 7: 1293-1297
25. Lapchak PL, Araujo DM, Hilt DC, Scheng J, Jiao S (1997) Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease. Brain Res 777: 153-160
26. Martinez-Serrano A, Björklund A (1996) Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells. J Neurosci 16: 4604-4616
27. Nakao N, Brundi P (1997) Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience 76: 749-761
28. Olanow CW, Kordower JH, Freeman TB (1996) Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19: 102-109
29. Papp MI, Lantos PL (1992) Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy. J Neurol Sci 107: 172-182
30. Papp MI, Lantos PL (1994) The distribution of oligodendroglial inclusions in multiple system atrophy and ist relevance to clinical symptomatology. Brain 117: 235-243
31. Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrom), J Neurol Sci 94: 79-100
32. Perez-Navarro E, Arenas E, Reiriz J, Calvo N, Alberch J (1996) Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage. Neuroscience 75: 345-352
33. Peschanski M, Cesaro P, Hantraye P (1996) What is needed versus what would be interesting to know bevor undertaking neural transplantation in patients with Huntington's disease. Neuroscience 71: 899-900
34. Pifl C, Giros B, Caron MG (1993) Dopamine transporter expression confers cytoloxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J Neurosci 13: 4246-4253
35. Probst-Cousin S, Rickert CH, Schmid KW, Gullotta F (1998) Cell death mechanisms in multiple system atrophy. J Neuropathol Exp Neurol 57: 814-821
36. Quinn NP (1994) Multiple system atrophy. In: Marsden CD, Fahn S (eds) Movement disorders, vol 3. Butterworth-Heinemann, London, pp 262-281
37. Sauer H, Oertel WH (1994) Progressive degeneration of nigrostriatal dopaminergic neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59: 401-415
38. Schulz JB, Hensha DR, Jenkin BG, Ferrant RJ, Kowal NW, Rose BR, Beal M (1994) 3-Acetylpyridine produces age-dependent excitotoxic lesions in the rat striatum. J Cereb Blood Flow Metab 14: 1024-1029
39. Sonsalla PK, Giovanni A, Sieber BA, Donne KD, Manzino L (1992) Characteristics of dopaminergic neurotoxicity produced by MPTP and metamphetamine. Ann N Y Acad Sci 648: 229-238
40. Spokes EG, Bannister R, Oppenheimer DR (1979) Multiple system atrophy with autonomic failure - clinical, histological and neurochemical observations on four cases. J Neurol Sci 43: 59-82
41. Storey E, Hyman BT, Jenkins B, Brouillet E, Miller JM, Rosen BR, Beal MF (1992) 1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism. J Neurochem 58: 1975-1978
42. Sundstrom E, Goldstein M, Jonsson G (1986) Uptake inhibition protects nigro-striatal dopamine neurons from the neurotoxicity of 1-methyl-4-phenylpyridine (MPP+) in mice. Eur J Pharmacol 131: 289-292
43. Takada M, Kono T (1993) 3-Acetylpyridinc neurotoxicity to the nigrostriatal dopamine system in mice. Neurosci Lett 161: 211-214
44. Tison F, Wenning GK, Daniel SE, Quinn NP (1995) The pathophysiology of parkinsonism in multiple sytem atrophy. Eur J Neurol 2: 435-444
45. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, Quinn NP (1994) Clinical fea-tures and natural history of multiple system atrophy. An analysis of 100 cases. Brain 117:835-845
46. Wenning GK, Granata R, Laboyrie PM. Quinn NP, Jenner P, Marsden CD (1996a) Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov Disord 11: 522-532
47. Wenning GK, Laboyrie P, Granata R, Quinn NP, Jenner P, Marsden CD (1996b) Reversal of behavioural abnormalities in a rat model of striatonigral degeneration following intrastriatal transplantation of pure mesencephalic and mesencephalic-striatal cografts. Mov Disord 11: 44 (abstract)
48. Wenning GK, Tison F, Elliott L, Quinn NP, Daniel SE (1996c) Olivopontocerebellar pathology in multiple system atrophy. Mov Disord 11: 157-162
49. Wenning GK, Odin P. Morrish P, Rehnerona S, Widner H, Brundin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle G, Björklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O (1997a) Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 42: 95-107
50. Wenning GK, Quinn NP (1997b) Parkinsonism. Multiple system atrophy. Baillicres Clin Neurol 6: 187-204
51. Winkler C, Sauer H, Lee CS, Björklund A (1996) Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 16: 7206-7215
52. Wüllner U, Young AB, Penney JB, Beal MF (1994) 3-Nitropropionic acid toxicity in the striatum. J Neurochem 63: 1772-1781
53. Wüllner U, Weller N, Groscurt P, Loschmann PA, Schulz JB, Müller I, Klockgether T (1997) Evidence for an active type of cell death with ultrastructural features distinct from apoptosis: the effects of 3-acetylpyridine neurotoxicity. Neuroscience 81: 721-734
54. Yurek DM, Collier TJ, Sladek JR Jr (1990) Embryonic mesencephalic and striatal cografts: development of grafted dopamine neurons and functional recovery. Exp Neurol 109: 191-199